Quentin Descat

Head Global Cardiovascular – Commercial Launch Brands Lead

CASE STUDY

The Employer Experience Proposition

Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.

Quentin Descat

Head Global Cardiovascular – Commercial Launch Brands Lead

CASE STUDY

The Employer Experience Proposition

Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.

Speakers

Sample of Keynote Speakers and their Case Studies

Quentin Descat

Head Global Cardiovascular – Commercial Launch Brands Lead

CASE STUDY

The Employer Experience Proposition

Global Internal Benchmark for key HR Metrics. Key HR Metrics are aggregated and shared globally between different regions so each region can compare their own results with others within Sony. This is a good use case of how own data is utilised and leveraged in a global scale.

Слайдшоу

Berislav Jozic

Managing Director Integrated Risk Management

CASE STUDY

Operational Risk Driven by Third Parties

Third parties are continuously becoming more relevant source of operational risk, which is getting more and more complex to manage. DORA brought additional complexities to the topic, but in truth the management of third parties was always one of the key areas of operational risk issues.

The presentation will give an overview of the main topics and challenges of supply chain and logistics in an environment with dangerous chemicals and quality-sensitive products. You will get insights regarding a make-or-buy decision for storage and distribution and several other best practices. With regard to the actual “world of transformation”, there will also be interesting thoughts about deployment & transformation — especially how to find the right factors in scaling the final positioning of a so-called minimum viable product.

Show More

Gabriel Andrade

Director

CASE STUDY

A Risk Management Framework for Central Banks

Risk management is a key asset to all successful organizations. But how to ensure risk management efficacy is still an open debate, particularly at Central Banis.

Using Banco de Portugal risk management framework as a guide, we will discuss the main opportunities and challenges that a strong risk management culture can bring to this kind of institutions.

The estimation of risk-neutral default probabilities in the context of securitisation swaps, MBS/ABS bonds and collateralised debt obligations always represents a challenge, often leading to disagreement among market participants. In this talk, we present a simple methodology to rapidly estimate upper and lower bounds on default and prepayment risk, as implied by the risk-neutral valuation theory. Some examples are provided in the context of mortgage-backed securities (MBS) and collateralised debt obligations (CDOs). Assumptions made are exposed in detail to analyse the weak and strong points of this methodology.

Show More

Stefan Zima

Head of Group Regulatory Compliance

CASE STUDY

The road to data driven prudential compliance

How RBI Group has established prudential compliance newly with experience ofits Data Transformation journey towards business value and strategy leveraging federated data governance with digitalization, Reglechs and Al capabilities.

Plasma-derived therapies (PDTs) are life-changing and life-sustaining medicines that people with rare and complex chronic diseases around the world rely on every day. Plasma is a scarce resource that cannot be made artificially, and hundreds of plasma donations – and sometimes over a thousand – are needed to make enough therapy for just one patient for one year. This is a complex, large-scale business in which growth in demand for therapies is outpacing supply – and patients’ lives are at stake. At Takeda, our priority is to ensure a sustained supply of PDTs for the patients worldwide who depend on them. This presentation will share more on how we harness data, digital, and technology (DD&T) to make every step of our end-to-end process better, faster, and more efficient – from using AI to advance operational efficiencies to developing novel device and digital solutions for patients.

Show More

Annelie Rivera Larsson

Head of Operational Risk Processes

CASE STUDY

Risk Culture, Cultivating a Risk-Aware Culture Throughout the Organisation

This presentation aims to share a business perspective on the Basel IV implementation.

In this session, we delve into the transformative world of omnichannel communication within global and local medical affairs. We will explore strategies and requirements for implementing an omnichannel approach, ensuring healthcare professionals have seamless access to diverse resources across multiple platforms. The session will highlight how leveraging data can refine and personalise communication methods, thus enhancing their impact on the target audience. Additionally, the presentation will address the importance of facilitating effective cross-functional communication among medical and commercial teams, especially in fostering a unified strategy. Finally, we will explore methods to tailor content and messaging to suit the diverse preferences of different healthcare professionals and stakeholders. This session promises to offer valuable insights and practical tools for anyone looking to enhance their communication strategies in the rapidly evolving healthcare sector.

Show More

Janine Mooij-Rebel

Head Operational & Enterprise Risk, Retail

CASE STUDY

Reducing Control Pressure within the Operational Risk Control Framework

Emphasising the importance of user-centred design principles to create engaging, effective, and accessible DTx solutions for patients with varying needs and abilities.

Welcome to “Charting the Course: Our Influence on the HCP/Customer Engagement Trek”. Today, we embark on a journey to explore our impact on the ever-evolving landscape of healthcare professional (HCP) and customer engagement. In a world shaped by technology, ethics, and personalisation, our role as navigators of this journey is pivotal. Throughout this discourse, we’ll delve into key topics that define our approach, from leveraging technology to building meaningful connections. Join me as we navigate through these waters together, shaping not just outcomes, but the very fabric of trust and collaboration that underpins every meaningful engagement.

Show More
Thumbnail 1
Thumbnail 2
Thumbnail 3
Thumbnail 4
Thumbnail 5

Berislav Jozic

Managing Director Integrated Risk Management

CASE STUDY

Operational Risk Driven by Third Parties

Third parties are continuously becoming more relevant source of operational risk, which is getting more and more complex to manage. DORA brought additional complexities to the topic, but in truth the management of third parties was always one of the key areas of operational risk issues.

The presentation will give an overview of the main topics and challenges of supply chain and logistics in an environment with dangerous chemicals and quality-sensitive products. You will get insights regarding a make-or-buy decision for storage and distribution and several other best practices. With regard to the actual “world of transformation”, there will also be interesting thoughts about deployment & transformation — especially how to find the right factors in scaling the final positioning of a so-called minimum viable product.

Show More

Gabriel Andrade

Director

CASE STUDY

A Risk Management Framework for Central Banks

Risk management is a key asset to all successful organizations. But how to ensure risk management efficacy is still an open debate, particularly at Central Banis.

Using Banco de Portugal risk management framework as a guide, we will discuss the main opportunities and challenges that a strong risk management culture can bring to this kind of institutions.

The estimation of risk-neutral default probabilities in the context of securitisation swaps, MBS/ABS bonds and collateralised debt obligations always represents a challenge, often leading to disagreement among market participants. In this talk, we present a simple methodology to rapidly estimate upper and lower bounds on default and prepayment risk, as implied by the risk-neutral valuation theory. Some examples are provided in the context of mortgage-backed securities (MBS) and collateralised debt obligations (CDOs). Assumptions made are exposed in detail to analyse the weak and strong points of this methodology.

Show More

Janine Mooij-Rebel

Head Operational & Enterprise Risk, Retail

CASE STUDY

Reducing Control Pressure within the Operational Risk Control Framework

Emphasising the importance of user-centred design principles to create engaging, effective, and accessible DTx solutions for patients with varying needs and abilities.

Welcome to “Charting the Course: Our Influence on the HCP/Customer Engagement Trek”. Today, we embark on a journey to explore our impact on the ever-evolving landscape of healthcare professional (HCP) and customer engagement. In a world shaped by technology, ethics, and personalisation, our role as navigators of this journey is pivotal. Throughout this discourse, we’ll delve into key topics that define our approach, from leveraging technology to building meaningful connections. Join me as we navigate through these waters together, shaping not just outcomes, but the very fabric of trust and collaboration that underpins every meaningful engagement.

Show More

Stefan Zima

Head of Group Regulatory Compliance

CASE STUDY

The road to data driven prudential compliance

How RBI Group has established prudential compliance newly with experience ofits Data Transformation journey towards business value and strategy leveraging federated data governance with digitalization, Reglechs and Al capabilities.

Plasma-derived therapies (PDTs) are life-changing and life-sustaining medicines that people with rare and complex chronic diseases around the world rely on every day. Plasma is a scarce resource that cannot be made artificially, and hundreds of plasma donations – and sometimes over a thousand – are needed to make enough therapy for just one patient for one year. This is a complex, large-scale business in which growth in demand for therapies is outpacing supply – and patients’ lives are at stake. At Takeda, our priority is to ensure a sustained supply of PDTs for the patients worldwide who depend on them. This presentation will share more on how we harness data, digital, and technology (DD&T) to make every step of our end-to-end process better, faster, and more efficient – from using AI to advance operational efficiencies to developing novel device and digital solutions for patients.

Show More

Annelie Rivera Larsson

Head of Operational Risk Processes

CASE STUDY

Risk Culture, Cultivating a Risk-Aware Culture Throughout the Organisation

This presentation aims to share a business perspective on the Basel IV implementation.

In this session, we delve into the transformative world of omnichannel communication within global and local medical affairs. We will explore strategies and requirements for implementing an omnichannel approach, ensuring healthcare professionals have seamless access to diverse resources across multiple platforms. The session will highlight how leveraging data can refine and personalise communication methods, thus enhancing their impact on the target audience. Additionally, the presentation will address the importance of facilitating effective cross-functional communication among medical and commercial teams, especially in fostering a unified strategy. Finally, we will explore methods to tailor content and messaging to suit the diverse preferences of different healthcare professionals and stakeholders. This session promises to offer valuable insights and practical tools for anyone looking to enhance their communication strategies in the rapidly evolving healthcare sector.

Show More